Amoxicillin/Ambroxol Hydrochloride

阿莫西林/盐酸氨溴索

Report date: 2025/07/22 15:55:27

Base Information

Drug NameAmoxicillin/Ambroxol Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsSodium channel alpha subunit modulators
TargetsBacterial penicillin-binding proteinSodium channel alpha subunit
Therapy Area/IndicationsOtitis MediaTracheobronchomegalyAsthma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes AmoxicillinAmbroxol Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Huaxi United Technology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Huaxi United Technology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsOtitis MediaTracheobronchomegalyAsthma +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A